Tasipimidine

N/A

Report date: 2025/05/15 20:00:08
NME

Base Information

Drug NameTasipimidine
Drug Alias NameODM-105ODM 105ORM 19695
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2a adrenergic receptor agonists
TargetsAlpha-2a adrenergic receptor
Therapy Area/IndicationsMental DisordersFearAnxiety +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMental DisordersSleep Initiation and Maintenance Disorders
Inactive IndicationsFearAnxiety

Other Information

ATC CodeN/A
Related LinksN/A